TransMedics Group, Inc. Basic Shares Outstanding (Weighted Average)
TransMedics Group, Inc. (TMDX) reported Basic Shares Outstanding (Weighted Average) of 34.58 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 34.58M shares, a 1.97% increase year-over-year.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 34.38M shares, a 1.96% increase year-over-year.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 34.22M shares, a 1.87% increase year-over-year.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 34.11M shares, a 2.01% increase year-over-year.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 33.99M shares, a 2.30% increase from fiscal 2024.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 33.23M shares, a 2.19% increase from fiscal 2023.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 32.52M shares, a 10.02% increase from fiscal 2022.
- TransMedics Group, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 29.56M shares, a 7.02% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 34.58M shares 10-Q · filed 2026-08-04 | 34.48M shares 10-Q · filed 2026-08-04 | 34.40M shares derived: average of 3 quarters · filed 2026-08-04 | 34.32M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 34.38M shares 10-Q · filed 2026-05-05 | 34.30M shares derived: average of 2 quarters · filed 2026-05-05 | 34.24M shares derived: average of 3 quarters · filed 2026-05-05 | 34.16M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | 34.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 34.17M shares derived: average of 2 quarters · filed 2026-02-24 | 34.08M shares derived: average of 3 quarters · filed 2026-08-04 | 33.99M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 34.11M shares 10-Q · filed 2025-10-29 | 34.01M shares derived: average of 2 quarters · filed 2026-08-04 | 33.92M shares 10-Q · filed 2025-10-29 | 33.84M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | 33.91M shares 10-Q · filed 2026-08-04 | 33.82M shares 10-Q · filed 2026-08-04 | 33.74M shares derived: average of 3 quarters · filed 2026-08-04 | 33.67M shares derived: average of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | 33.72M shares 10-Q · filed 2026-05-05 | 33.66M shares derived: average of 2 quarters · filed 2026-05-05 | 33.59M shares derived: average of 3 quarters · filed 2026-05-05 | 33.47M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 33.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 33.52M shares derived: average of 2 quarters · filed 2026-02-24 | 33.39M shares derived: average of 3 quarters · filed 2026-02-24 | 33.23M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 33.44M shares 10-Q · filed 2025-10-29 | 33.28M shares derived: average of 2 quarters · filed 2025-10-29 | 33.11M shares 10-Q · filed 2025-10-29 | 32.99M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 33.12M shares 10-Q · filed 2025-07-30 | 32.94M shares 10-Q · filed 2025-07-30 | 32.84M shares derived: average of 3 quarters · filed 2026-02-24 | 32.78M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 32.76M shares 10-Q · filed 2025-05-08 | 32.70M shares derived: average of 2 quarters · filed 2026-02-24 | 32.67M shares derived: average of 3 quarters · filed 2026-02-24 | 32.64M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 32.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 32.63M shares derived: average of 2 quarters · filed 2026-02-24 | 32.60M shares derived: average of 3 quarters · filed 2026-02-24 | 32.52M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 32.61M shares 10-Q · filed 2024-10-29 | 32.58M shares derived: average of 2 quarters · filed 2024-10-29 | 32.47M shares 10-Q · filed 2024-10-29 | 32.36M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 32.55M shares 10-Q · filed 2024-08-01 | 32.40M shares 10-Q · filed 2024-08-01 | 32.28M shares derived: average of 3 quarters · filed 2025-02-27 | 31.77M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 32.26M shares 10-Q · filed 2024-05-02 | 32.15M shares derived: average of 2 quarters · filed 2025-02-27 | 31.51M shares derived: average of 3 quarters · filed 2025-02-27 | 30.63M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 32.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 31.13M shares derived: average of 2 quarters · filed 2025-02-27 | 30.08M shares derived: average of 3 quarters · filed 2025-02-27 | 29.56M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 30.23M shares 10-Q · filed 2023-11-08 | 29.11M shares derived: average of 2 quarters · filed 2023-11-08 | 28.73M shares 10-Q · filed 2023-11-08 | 28.48M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 27.98M shares 10-Q · filed 2023-08-04 | 27.97M shares 10-Q · filed 2023-08-04 | 27.90M shares derived: average of 3 quarters · filed 2024-02-27 | 27.85M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 27.95M shares 10-Q · filed 2023-05-04 | 27.86M shares derived: average of 2 quarters · filed 2024-02-27 | 27.81M shares derived: average of 3 quarters · filed 2024-02-27 | 27.76M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 27.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 27.74M shares derived: average of 2 quarters · filed 2024-02-27 | 27.70M shares derived: average of 3 quarters · filed 2024-02-27 | 27.62M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 27.70M shares 10-Q · filed 2022-11-04 | 27.66M shares derived: average of 2 quarters · filed 2022-11-04 | 27.56M shares 10-Q · filed 2022-11-04 | 27.46M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 27.62M shares 10-Q · filed 2022-08-03 | 27.50M shares 10-Q · filed 2022-08-03 | 27.38M shares derived: average of 3 quarters · filed 2023-02-27 | 27.32M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 27.37M shares 10-Q · filed 2022-05-05 | 27.26M shares derived: average of 2 quarters · filed 2023-02-27 | 27.23M shares derived: average of 3 quarters · filed 2023-02-27 | 26.25M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 27.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 27.16M shares derived: average of 2 quarters · filed 2023-02-27 | 25.88M shares derived: average of 3 quarters · filed 2023-02-27 | 24.70M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 27.16M shares 10-Q · filed 2021-11-09 | 25.24M shares derived: average of 2 quarters · filed 2021-11-09 | 23.89M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 23.33M shares 10-Q · filed 2021-08-06 | 22.26M shares 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | 21.22M shares 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |